• レポートコード:QAF27587 • 出版社/出版日:QYResearch / 2021年3月24日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、143ページ • 納品方法:Eメール(即日納品) • 産業分類:医薬品 |
Single User | ¥600,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査資料では、世界のバイオ医薬品緩衝液市場について種類別(リン酸緩衝液、酢酸緩衝液、TRIS緩衝液、その他)、用途別(研究機関、製薬業、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・バイオ医薬品緩衝液市場の概要 ・世界の主要地域別バイオ医薬品緩衝液市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のバイオ医薬品緩衝液市場規模2016-2021:種類別(リン酸緩衝液、酢酸緩衝液、TRIS緩衝液、その他) ・世界のバイオ医薬品緩衝液市場予測2012-2027:種類別(リン酸緩衝液、酢酸緩衝液、TRIS緩衝液、その他) ・世界のバイオ医薬品緩衝液市場規模2016-2021:用途別(研究機関、製薬業、その他) ・世界のバイオ医薬品緩衝液市場予測2012-2027:用途別(研究機関、製薬業、その他) ・バイオ医薬品緩衝液のアメリカ市場規模と予測2016-2021 ・バイオ医薬品緩衝液のヨーロッパ市場規模と予測2016-2021 ・バイオ医薬品緩衝液の中国市場規模と予測2016-2021 ・バイオ医薬品緩衝液の日本市場規模と予測2016-2021 ・バイオ医薬品緩衝液の東南アジア市場規模と予測2016-2021 ・バイオ医薬品緩衝液のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 (Avantor、Alfa Aesar (Thermo Fisher)、Merck、Lonza、Bio-Rad、BD、GE Healthcare、Promega Corporation、Hamilton Company、XZL BIO-TECHNOLOGY、SRL) ・バイオ医薬品緩衝液の製造コスト分析 ・販売チャネル、流通業者、顧客 ・バイオ医薬品緩衝液の市場動向・機会・課題 ・調査の結論 |
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share in 2017.
Market Analysis and Insights: Global Bio Pharma Buffer Market
The global Bio Pharma Buffer market was valued at US$ 841.4 in 2020 and will reach US$ 1277 million by the end of 2027, growing at a CAGR of 7.2% during 2022-2027.
Global Bio Pharma Buffer Scope and Market Size
The global Bio Pharma Buffer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bio Pharma Buffer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Phosphates Buffer
Acetates Buffer
TRIS Buffer
Others
Segment by Application
Research Institution
Pharmaceutical Industry
Others
The Bio Pharma Buffer market is analysed and market size information is provided by regions (countries). Segment by Application, the Bio Pharma Buffer market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
1 Bio Pharma Buffer Market Overview
1.1 Bio Pharma Buffer Product Scope
1.2 Bio Pharma Buffer Segment by Type
1.2.1 Global Bio Pharma Buffer Sales by Type (2016 & 2021 & 2027)
1.2.2 Phosphates Buffer
1.2.3 Acetates Buffer
1.2.4 TRIS Buffer
1.2.5 Others
1.3 Bio Pharma Buffer Segment by Application
1.3.1 Global Bio Pharma Buffer Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Bio Pharma Buffer Market Estimates and Forecasts (2016-2027)
1.4.1 Global Bio Pharma Buffer Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Bio Pharma Buffer Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Bio Pharma Buffer Price Trends (2016-2027)
2 Bio Pharma Buffer Estimates and Forecasts by Region
2.1 Global Bio Pharma Buffer Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Bio Pharma Buffer Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Bio Pharma Buffer Sales Market Share by Region (2016-2021)
2.2.2 Global Bio Pharma Buffer Revenue Market Share by Region (2016-2021)
2.3 Global Bio Pharma Buffer Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Bio Pharma Buffer Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Bio Pharma Buffer Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Bio Pharma Buffer Estimates and Projections (2016-2027)
2.4.2 Europe Bio Pharma Buffer Estimates and Projections (2016-2027)
2.4.3 China Bio Pharma Buffer Estimates and Projections (2016-2027)
2.4.4 Japan Bio Pharma Buffer Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Bio Pharma Buffer Estimates and Projections (2016-2027)
2.4.6 India Bio Pharma Buffer Estimates and Projections (2016-2027)
3 Global Bio Pharma Buffer Competition Landscape by Players
3.1 Global Top Bio Pharma Buffer Players by Sales (2016-2021)
3.2 Global Top Bio Pharma Buffer Players by Revenue (2016-2021)
3.3 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio Pharma Buffer as of 2020)
3.4 Global Bio Pharma Buffer Average Price by Company (2016-2021)
3.5 Manufacturers Bio Pharma Buffer Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Bio Pharma Buffer Market Size by Type
4.1 Global Bio Pharma Buffer Historic Market Review by Type (2016-2021)
4.1.1 Global Bio Pharma Buffer Sales Market Share by Type (2016-2021)
4.1.2 Global Bio Pharma Buffer Revenue Market Share by Type (2016-2021)
4.1.3 Global Bio Pharma Buffer Price by Type (2016-2021)
4.2 Global Bio Pharma Buffer Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Bio Pharma Buffer Sales Forecast by Type (2022-2027)
4.2.2 Global Bio Pharma Buffer Revenue Forecast by Type (2022-2027)
4.2.3 Global Bio Pharma Buffer Price Forecast by Type (2022-2027)
5 Global Bio Pharma Buffer Market Size by Application
5.1 Global Bio Pharma Buffer Historic Market Review by Application (2016-2021)
5.1.1 Global Bio Pharma Buffer Sales Market Share by Application (2016-2021)
5.1.2 Global Bio Pharma Buffer Revenue Market Share by Application (2016-2021)
5.1.3 Global Bio Pharma Buffer Price by Application (2016-2021)
5.2 Global Bio Pharma Buffer Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Bio Pharma Buffer Sales Forecast by Application (2022-2027)
5.2.2 Global Bio Pharma Buffer Revenue Forecast by Application (2022-2027)
5.2.3 Global Bio Pharma Buffer Price Forecast by Application (2022-2027)
6 North America Bio Pharma Buffer Market Facts & Figures
6.1 North America Bio Pharma Buffer Sales by Company
6.1.1 North America Bio Pharma Buffer Sales by Company (2016-2021)
6.1.2 North America Bio Pharma Buffer Revenue by Company (2016-2021)
6.2 North America Bio Pharma Buffer Sales Breakdown by Type
6.2.1 North America Bio Pharma Buffer Sales Breakdown by Type (2016-2021)
6.2.2 North America Bio Pharma Buffer Sales Breakdown by Type (2022-2027)
6.3 North America Bio Pharma Buffer Sales Breakdown by Application
6.3.1 North America Bio Pharma Buffer Sales Breakdown by Application (2016-2021)
6.3.2 North America Bio Pharma Buffer Sales Breakdown by Application (2022-2027)
7 Europe Bio Pharma Buffer Market Facts & Figures
7.1 Europe Bio Pharma Buffer Sales by Company
7.1.1 Europe Bio Pharma Buffer Sales by Company (2016-2021)
7.1.2 Europe Bio Pharma Buffer Revenue by Company (2016-2021)
7.2 Europe Bio Pharma Buffer Sales Breakdown by Type
7.2.1 Europe Bio Pharma Buffer Sales Breakdown by Type (2016-2021)
7.2.2 Europe Bio Pharma Buffer Sales Breakdown by Type (2022-2027)
7.3 Europe Bio Pharma Buffer Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Bio Pharma Buffer Market Facts & Figures
8.1 China Bio Pharma Buffer Sales by Company
8.1.1 China Bio Pharma Buffer Sales by Company (2016-2021)
8.1.2 China Bio Pharma Buffer Revenue by Company (2016-2021)
8.2 China Bio Pharma Buffer Sales Breakdown by Type
8.2.1 China Bio Pharma Buffer Sales Breakdown by Type (2016-2021)
8.2.2 China Bio Pharma Buffer Sales Breakdown by Type (2022-2027)
8.3 China Bio Pharma Buffer Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)
9 Japan Bio Pharma Buffer Market Facts & Figures
9.1 Japan Bio Pharma Buffer Sales by Company
9.1.1 Japan Bio Pharma Buffer Sales by Company (2016-2021)
9.1.2 Japan Bio Pharma Buffer Revenue by Company (2016-2021)
9.2 Japan Bio Pharma Buffer Sales Breakdown by Type
9.2.1 Japan Bio Pharma Buffer Sales Breakdown by Type (2016-2021)
9.2.2 Japan Bio Pharma Buffer Sales Breakdown by Type (2022-2027)
9.3 Japan Bio Pharma Buffer Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Bio Pharma Buffer Market Facts & Figures
10.1 Southeast Asia Bio Pharma Buffer Sales by Company
10.1.1 Southeast Asia Bio Pharma Buffer Sales by Company (2016-2021)
10.1.2 Southeast Asia Bio Pharma Buffer Revenue by Company (2016-2021)
10.2 Southeast Asia Bio Pharma Buffer Sales Breakdown by Type
10.2.1 Southeast Asia Bio Pharma Buffer Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Bio Pharma Buffer Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Bio Pharma Buffer Sales Breakdown by Application
10.3.1 Southeast Asia K Liter Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Liter Sales Breakdown by Application (2022-2027)
11 India Bio Pharma Buffer Market Facts & Figures
11.1 India Bio Pharma Buffer Sales by Company
11.1.1 India Bio Pharma Buffer Sales by Company (2016-2021)
11.1.2 India Bio Pharma Buffer Revenue by Company (2016-2021)
11.2 India Bio Pharma Buffer Sales Breakdown by Type
11.2.1 India Bio Pharma Buffer Sales Breakdown by Type (2016-2021)
11.2.2 India Bio Pharma Buffer Sales Breakdown by Type (2022-2027)
11.3 India Bio Pharma Buffer Sales Breakdown by Application
11.3.1 India Bio Pharma Buffer Sales Breakdown by Application (2016-2021)
11.3.2 India Bio Pharma Buffer Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Bio Pharma Buffer Business
12.1 Avantor
12.1.1 Avantor Corporation Information
12.1.2 Avantor Business Overview
12.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Avantor Bio Pharma Buffer Products Offered
12.1.5 Avantor Recent Development
12.2 Alfa Aesar (Thermo Fisher)
12.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
12.2.2 Alfa Aesar (Thermo Fisher) Business Overview
12.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Products Offered
12.2.5 Alfa Aesar (Thermo Fisher) Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Bio Pharma Buffer Products Offered
12.3.5 Merck Recent Development
12.4 Lonza
12.4.1 Lonza Corporation Information
12.4.2 Lonza Business Overview
12.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lonza Bio Pharma Buffer Products Offered
12.4.5 Lonza Recent Development
12.5 Bio-Rad
12.5.1 Bio-Rad Corporation Information
12.5.2 Bio-Rad Business Overview
12.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bio-Rad Bio Pharma Buffer Products Offered
12.5.5 Bio-Rad Recent Development
12.6 BD
12.6.1 BD Corporation Information
12.6.2 BD Business Overview
12.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.6.4 BD Bio Pharma Buffer Products Offered
12.6.5 BD Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Corporation Information
12.7.2 GE Healthcare Business Overview
12.7.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GE Healthcare Bio Pharma Buffer Products Offered
12.7.5 GE Healthcare Recent Development
12.8 Promega Corporation
12.8.1 Promega Corporation Corporation Information
12.8.2 Promega Corporation Business Overview
12.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Promega Corporation Bio Pharma Buffer Products Offered
12.8.5 Promega Corporation Recent Development
12.9 Hamilton Company
12.9.1 Hamilton Company Corporation Information
12.9.2 Hamilton Company Business Overview
12.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hamilton Company Bio Pharma Buffer Products Offered
12.9.5 Hamilton Company Recent Development
12.10 XZL BIO-TECHNOLOGY
12.10.1 XZL BIO-TECHNOLOGY Corporation Information
12.10.2 XZL BIO-TECHNOLOGY Business Overview
12.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Products Offered
12.10.5 XZL BIO-TECHNOLOGY Recent Development
12.11 SRL
12.11.1 SRL Corporation Information
12.11.2 SRL Business Overview
12.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.11.4 SRL Bio Pharma Buffer Products Offered
12.11.5 SRL Recent Development
13 Bio Pharma Buffer Manufacturing Cost Analysis
13.1 Bio Pharma Buffer Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bio Pharma Buffer
13.4 Bio Pharma Buffer Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bio Pharma Buffer Distributors List
14.3 Bio Pharma Buffer Customers
15 Market Dynamics
15.1 Bio Pharma Buffer Market Trends
15.2 Bio Pharma Buffer Drivers
15.3 Bio Pharma Buffer Market Challenges
15.4 Bio Pharma Buffer Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Bio Pharma Buffer Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Bio Pharma Buffer Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Bio Pharma Buffer Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Bio Pharma Buffer Sales (K Liter) by Region (2016-2021)
Table 5. Global Bio Pharma Buffer Sales Market Share by Region (2016-2021)
Table 6. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Bio Pharma Buffer Revenue Share by Region (2016-2021)
Table 8. Global Bio Pharma Buffer Sales (K Liter) Forecast by Region (2022-2027)
Table 9. Global Bio Pharma Buffer Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Bio Pharma Buffer Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Bio Pharma Buffer Revenue Share Forecast by Region (2022-2027)
Table 12. Global Bio Pharma Buffer Sales (K Liter) of Key Companies (2016-2021)
Table 13. Global Bio Pharma Buffer Sales Share by Company (2016-2021)
Table 14. Global Bio Pharma Buffer Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Bio Pharma Buffer Revenue Share by Company (2016-2021)
Table 16. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Pharma Buffer as of 2020)
Table 17. Global Bio Pharma Buffer Average Price (USD/Liter) of Key Company (2016-2021)
Table 18. Manufacturers Bio Pharma Buffer Manufacturing Sites and Area Served
Table 19. Manufacturers Bio Pharma Buffer Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Bio Pharma Buffer Sales (K Liter) by Type (2016-2021)
Table 22. Global Bio Pharma Buffer Sales Share by Type (2016-2021)
Table 23. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Bio Pharma Buffer Price (USD/Liter) by Type (2016-2021)
Table 25. Global Bio Pharma Buffer Sales Share by Type (2022-2027)
Table 26. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Bio Pharma Buffer Revenue Share by Type (2022-2027)
Table 28. Global Bio Pharma Buffer Price (USD/Liter) by Type (2022-2027)
Table 29. Global Bio Pharma Buffer Sales (K Liter) by Application (2016-2021)
Table 30. Global Bio Pharma Buffer Sales Share by Application (2016-2021)
Table 31. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Bio Pharma Buffer Price (USD/Liter) by Application (2016-2021)
Table 33. Global Bio Pharma Buffer Sales (K Liter) by Application (2022-2027)
Table 34. Global Bio Pharma Buffer Sales Share by Application (2022-2027)
Table 35. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Bio Pharma Buffer Revenue Share by Application (2022-2027)
Table 37. Global Bio Pharma Buffer Price (USD/Liter) by Application (2022-2027)
Table 38. North America Bio Pharma Buffer Sales (K Liter) by Company (2016-2021)
Table 39. North America Bio Pharma Buffer Sales Market Share by Company (2016-2021)
Table 40. North America Bio Pharma Buffer Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Bio Pharma Buffer Revenue Market Share by Company (2016-2021)
Table 42. North America Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 43. North America Bio Pharma Buffer Sales Market Share by Type (2016-2021)
Table 44. North America Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 45. North America Bio Pharma Buffer Sales Market Share by Type (2022-2027)
Table 46. North America Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 47. North America Bio Pharma Buffer Sales Market Share by Application (2016-2021)
Table 48. North America Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 49. North America Bio Pharma Buffer Sales Market Share by Application (2022-2027)
Table 50. Europe Bio Pharma Buffer Sales (K Liter) by Company (2016-2021)
Table 51. Europe Bio Pharma Buffer Sales Market Share by Company (2016-2021)
Table 52. Europe Bio Pharma Buffer Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Bio Pharma Buffer Revenue Market Share by Company (2016-2021)
Table 54. Europe Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 55. Europe Bio Pharma Buffer Sales Market Share by Type (2016-2021)
Table 56. Europe Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 57. Europe Bio Pharma Buffer Sales Market Share by Type (2022-2027)
Table 58. Europe Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 59. Europe Bio Pharma Buffer Sales Market Share by Application (2016-2021)
Table 60. Europe Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 61. Europe Bio Pharma Buffer Sales Market Share by Application (2022-2027)
Table 62. China Bio Pharma Buffer Sales (K Liter) by Company (2016-2021)
Table 63. China Bio Pharma Buffer Sales Market Share by Company (2016-2021)
Table 64. China Bio Pharma Buffer Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Bio Pharma Buffer Revenue Market Share by Company (2016-2021)
Table 66. China Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 67. China Bio Pharma Buffer Sales Market Share by Type (2016-2021)
Table 68. China Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 69. China Bio Pharma Buffer Sales Market Share by Type (2022-2027)
Table 70. China Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 71. China Bio Pharma Buffer Sales Market Share by Application (2016-2021)
Table 72. China Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 73. China Bio Pharma Buffer Sales Market Share by Application (2022-2027)
Table 74. Japan Bio Pharma Buffer Sales (K Liter) by Company (2016-2021)
Table 75. Japan Bio Pharma Buffer Sales Market Share by Company (2016-2021)
Table 76. Japan Bio Pharma Buffer Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Bio Pharma Buffer Revenue Market Share by Company (2016-2021)
Table 78. Japan Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 79. Japan Bio Pharma Buffer Sales Market Share by Type (2016-2021)
Table 80. Japan Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 81. Japan Bio Pharma Buffer Sales Market Share by Type (2022-2027)
Table 82. Japan Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 83. Japan Bio Pharma Buffer Sales Market Share by Application (2016-2021)
Table 84. Japan Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 85. Japan Bio Pharma Buffer Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Bio Pharma Buffer Sales (K Liter) by Company (2016-2021)
Table 87. Southeast Asia Bio Pharma Buffer Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Bio Pharma Buffer Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Bio Pharma Buffer Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 91. Southeast Asia Bio Pharma Buffer Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 93. Southeast Asia Bio Pharma Buffer Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 95. Southeast Asia Bio Pharma Buffer Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 97. Southeast Asia Bio Pharma Buffer Sales Market Share by Application (2022-2027)
Table 98. India Bio Pharma Buffer Sales (K Liter) by Company (2016-2021)
Table 99. India Bio Pharma Buffer Sales Market Share by Company (2016-2021)
Table 100. India Bio Pharma Buffer Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Bio Pharma Buffer Revenue Market Share by Company (2016-2021)
Table 102. India Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 103. India Bio Pharma Buffer Sales Market Share by Type (2016-2021)
Table 104. India Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 105. India Bio Pharma Buffer Sales Market Share by Type (2022-2027)
Table 106. India Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 107. India Bio Pharma Buffer Sales Market Share by Application (2016-2021)
Table 108. India Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 109. India Bio Pharma Buffer Sales Market Share by Application (2022-2027)
Table 110. Avantor Corporation Information
Table 111. Avantor Description and Business Overview
Table 112. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 113. Avantor Bio Pharma Buffer Product
Table 114. Avantor Recent Development
Table 115. Alfa Aesar (Thermo Fisher) Corporation Information
Table 116. Alfa Aesar (Thermo Fisher) Description and Business Overview
Table 117. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 118. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product
Table 119. Alfa Aesar (Thermo Fisher) Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 123. Merck Bio Pharma Buffer Product
Table 124. Merck Recent Development
Table 125. Lonza Corporation Information
Table 126. Lonza Description and Business Overview
Table 127. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 128. Lonza Bio Pharma Buffer Product
Table 129. Lonza Recent Development
Table 130. Bio-Rad Corporation Information
Table 131. Bio-Rad Description and Business Overview
Table 132. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 133. Bio-Rad Bio Pharma Buffer Product
Table 134. Bio-Rad Recent Development
Table 135. BD Corporation Information
Table 136. BD Description and Business Overview
Table 137. BD Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 138. BD Bio Pharma Buffer Product
Table 139. BD Recent Development
Table 140. GE Healthcare Corporation Information
Table 141. GE Healthcare Description and Business Overview
Table 142. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 143. GE Healthcare Bio Pharma Buffer Product
Table 144. GE Healthcare Recent Development
Table 145. Promega Corporation Corporation Information
Table 146. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 147. Promega Corporation Description and Business Overview
Table 148. Promega Corporation Bio Pharma Buffer Product
Table 149. Promega Corporation Recent Development
Table 150. Hamilton Company Corporation Information
Table 151. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 152. Hamilton Company Description and Business Overview
Table 153. Hamilton Company Bio Pharma Buffer Product
Table 154. Hamilton Company Recent Development
Table 155. XZL BIO-TECHNOLOGY Corporation Information
Table 156. XZL BIO-TECHNOLOGY Description and Business Overview
Table 157. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 158. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product
Table 159. XZL BIO-TECHNOLOGY Recent Development
Table 160. SRL Corporation Information
Table 161. SRL Description and Business Overview
Table 162. SRL Bio Pharma Buffer Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 163. SRL Bio Pharma Buffer Product
Table 164. SRL Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Bio Pharma Buffer Distributors List
Table 168. Bio Pharma Buffer Customers List
Table 169. Bio Pharma Buffer Market Trends
Table 170. Bio Pharma Buffer Market Drivers
Table 171. Bio Pharma Buffer Market Challenges
Table 172. Bio Pharma Buffer Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio Pharma Buffer Product Picture
Figure 2. Global Bio Pharma Buffer Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bio Pharma Buffer Sales Market Share by Application in 2021 & 2027
Figure 6. Research Institution Examples
Figure 7. Pharmaceutical Industry Examples
Figure 8. Others Examples
Figure 9. Global Bio Pharma Buffer Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Bio Pharma Buffer Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Bio Pharma Buffer Sales (K Liter) Growth Rate (2016-2027)
Figure 12. Global Bio Pharma Buffer Price Trends Growth Rate (2016-2027) (USD/Liter)
Figure 13. Global Bio Pharma Buffer Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Bio Pharma Buffer Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Bio Pharma Buffer Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Bio Pharma Buffer Sales (K Liter) Growth Rate (2016-2027)
Figure 17. Europe Bio Pharma Buffer Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Bio Pharma Buffer Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Bio Pharma Buffer Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Bio Pharma Buffer Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Bio Pharma Buffer Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Bio Pharma Buffer Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Bio Pharma Buffer Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Bio Pharma Buffer Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Bio Pharma Buffer Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Bio Pharma Buffer Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Bio Pharma Buffer Players Market Share by Revenue in Bio Pharma Buffer: 2016 & 2020
Figure 28. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Bio Pharma Buffer Revenue Share by Type (2016-2021)
Figure 30. Global Bio Pharma Buffer Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Bio Pharma Buffer Revenue Share by Application (2016-2021)
Figure 32. Global Bio Pharma Buffer Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Bio Pharma Buffer Sales Market Share by Type in 2020
Figure 34. North America Bio Pharma Buffer Sales Market Share by Application in 2020
Figure 35. Europe Bio Pharma Buffer Sales Market Share by Type in 2020
Figure 36. Europe Bio Pharma Buffer Sales Market Share by Application in 2020
Figure 37. China Bio Pharma Buffer Sales Market Share by Type in 2020
Figure 38. China Bio Pharma Buffer Sales Market Share by Application in 2020
Figure 39. Japan Bio Pharma Buffer Sales Market Share by Type in 2020
Figure 40. Japan Bio Pharma Buffer Sales Market Share by Application in 2020
Figure 41. Southeast Asia Bio Pharma Buffer Sales Market Share by Type in 2020
Figure 42. Southeast Asia Bio Pharma Buffer Sales Market Share by Application in 2020
Figure 43. India Bio Pharma Buffer Sales Market Share by Type in 2020
Figure 44. India Bio Pharma Buffer Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Bio Pharma Buffer
Figure 47. Manufacturing Process Analysis of Bio Pharma Buffer
Figure 48. Bio Pharma Buffer Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed